Is a complete TLV/EPIT research report available?

No complete published report is available for tlv/EPIT (TLV/EPIT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

TLV/EPIT (TLV/EPIT)

Tel Aviv Stock Exchange: TLV/EPIT · ILA

ILA 365

+1.60 (+0.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TLV/EPIT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	104.9M
Revenue (ttm)	679K
Net income (ttm)	-27.5M
EPS (ttm)	-ILA 0.92
Shares out	29.9M
Volume	13,658
Beta	0.43

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 679K
Net income (ttm): -27.5M
EPS (ttm): -ILA 0.92
Market cap: 104.9M

All TLV/EPIT indicators

Market & fundamental data

Available fields

165

Groups with data

Currency

USD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	44
Employees Change	2%
Employees Change Percent	4.76
Enterprise value	ILA 79.1M
Exchange	Tel Aviv Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Devices
Industry PE	101.4
Isin	IL0011825911
Last refreshed	2026-08-02
Market cap	ILA 104.9M
Price	ILA 365
Price currency	ILA
Rev Per Employee	15,432.82x
Sector	Healthcare
Sector PE	61.79
Sector PE Fwd	12.46
Sic	3841
Symbol	tlv/EPIT
Website	https://epitomeemedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-26.18%
EV/Sales	116.49x
FCF yield	-28.85%
P/B ratio	1.27x
P/S ratio	154.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	ILA -2.1M
Net Income	ILA -27.5M
Net Income Growth Years	0%
Pretax Margin	-4,043.19%
Profit Per Employee	ILA -623,979
ROA	-16.25
Roa5y	-10.44
ROCE	-30.95
ROE	-28.75
Roe5y	-24.34
ROIC	-17.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-59.8%
Cagr3y	-19.09%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.01
Assets	ILA 105.5M
Cash	ILA 43.5M
Current Assets	ILA 44.1M
Current Liabilities	ILA 7.1M
Debt	ILA 17.7M
Debt Equity	ILA 0.21
Debt FCF	ILA -0.59
Equity	ILA 82.8M
Interest Coverage	-11.25
Liabilities	ILA 22.8M
Long Term Assets	ILA 61.4M
Long Term Liabilities	ILA 15.7M
Net Cash	ILA 25.8M
Net Cash By Market Cap	ILA 24.57
Net Cash Growth	-54.42%
Net Debt Equity	ILA -0.31
Tangible Book Value	ILA 82.8M
Tangible Book Value Per Share	ILA 2.77
WACC	7.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.23
Inventory Turnover	3.57
Net Working Capital	ILA -2.6M
Quick ratio	5.98
Working Capital	ILA 38.5M
Working Capital Turnover	ILA 0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-59.77%
200-day SMA	728.2
3Y total return	-47.04%
50-day SMA	544.3
50-day SMA vs 200-day SMA	50under200
All Time High	5,300
All Time High Change	-93.11%
All Time High Date	2021-12-15
All Time Low	249.4
All Time Low Change	46.51%
All Time Low Date	2024-08-12
ATR	26.35
Beta	0.43
Beta1y	0.31
Beta2y	0.97
Ch YTD	-40.17
High	367.8
High52	1,049
High52 Date	2026-01-21
High52ch	-65.17%
Low	344.9
Low52	315
Low52 Date	2026-07-28
Low52ch	16%
Ma50ch	-32.87%
Price vs 200-day SMA	-49.82%
RSI	30.2
RSI Monthly	33.94
RSI Weekly	28.79
Sharpe ratio	-1.41x
Sortino ratio	-1.75
Total Return	-0.97%
Tr YTD	-40.17
Tr1m	-46.02%
Tr1w	13.87%
Tr3m	-56.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -30.4M
Operating margin	-4,475.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,115,653%
Net Borrowing	-2,061,372.1
Shares Insiders	37.5%
Shares Institutions	12.78%
Shares Out	29,927,726
Shares Qo Q	1.65%
Shares Yo Y	0.97%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA -32M
Adjusted OCF	-26,208,548
Average Volume	48,555.05x
Bv Per Share	2.77
CAPEX	ILA -5.8M
Ch1m	-46.02
Ch1w	13.87
Ch1y	-59.77
Ch3m	-56.94
Ch3y	-47.04
Ch6m	-60.57
Change	0.44%
Change From Open	0.44
Close	363.8
Days Gap	0
Depreciation Amortization	1,543,731.8
Dollar Volume	4,990,633.2
Earnings Date	2026-08-14
EBIT	ILA -30.4M
EBITDA	ILA -28.8M
EPS	ILA -0.92
F Score	1
FCF	ILA -30.3M
FCF EV Yield	-38.25x
FCF Per Share	ILA -1.01
Financing CF	-1,954,244
Fiscal Year End	December
Founded	2,005
Investing CF	13,596,820
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Ma150	726.9
Ma150ch	-49.73%
Ma20	348.5
Ma20ch	4.84%
Net CF	-9,312,148
Next Earnings Date	2026-08-14
Open	363.8
Position In Range	89.52
Ppne	56,110,364.2
Price Date	2026-07-31
Ptbv Ratio	1.27
Relative Volume	0.19x
Revenue	679,044x
SBC By Revenue	263.38x
Share Based Comp	1,788,468
Tr6m	-60.57%
Volume	13,658
Z Score	2.65

TLV/EPIT (TLV/EPIT)

Coverage state: Market snapshot only — no published research

Generate the first TLV/EPIT analysis

Price

Financial snapshot

Fair-value bridge

Latest news · TLV/EPIT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TLV/EPIT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TLV/EPIT

Frequently asked questions